Diphtheria production

Bordetellapertussis, Corynehacterium diphtheriae, Vibrio cholerae). This is, to a large extent, a reflection of their inability to combat that host s deeper defences. Survival at these sites is largely due to firm attachment to the epithelial cells. Such organisms manifest disease through the production and release of toxins (see below). 

The single-component bacterial vaccines are listed in Table 15.1. For each vaccine, notes are provided of the basic material fkm which the vaccine is made, the salient production processes and tests for potency and for safety. The multicomponent vaccines that are made by blending together two or more of the single component vaccines are required to meet the potency and safety requirements for each of the single components that they contain. The best known of the combined bacterial vaccines is the adsorbed diphtheria, tetanus and pertussis vaccine (DTPerWac/Ads) that is used to immunize infants, and the adsorbed diphtheria and tetanus vaccine (DTWac/Ads) that is used to reinforce the immunity of school entrants. 

The quality control of both diphtheria and tetanus vaccines requires that the products are tested for the presence of free toxin, that is for specific toxicity due to inadequate detoxification with formalin, at the final-product stage. By this stage, however, the toxoid concentrates used in the preparation of the vaccines have been much diluted and, as the volume ofvaccine that can be inoculated into the test animals (guinea-pigs)... 

This is an acute, non-invasive infectious disease associated with the upper respiratory tract (Chapter 4). The incubation period is fiom 2 to 5 days although the disease remains communicable for up to 4 weeks. A low molecular weight toxin is produced which affects myocardium, nervous and adrenal tissues. Death results in 3-5% of infected children. Diphtheria immunization protects by stimulating the production of an antitoxin. This antitoxin will protect against the disease but not against infection of the respiratory... 

In the 1940s, diphtheria toxoid was combined with tetanus toxoid and whole cell pertussis vaccines, and later with the acellular pertussis vaccine. The diphtheria toxoid, tetanus toxoid, and acellular pertussis vaccine are part of the routine childhood immunization schedule. Diphtheria toxoid is also combined with tetanus toxoid and is commonly used as a booster vaccine. The pediatric product (DT) has a higher amount of diphtheria toxoid than does the adult product (Td). Diphtheria toxoid is not available as an individual vaccine. 

Polysaccharides of Corynebacterium diphtheriae yield D-galactose, pentoses and amino sugars on hydrolysis.79 D-Glucose and D-mannose are major hydrolytic products of the polysaccharide of Clostridium perfringens.80 Complete hydrolysis81 of the polysaccharide of the anthrax bacillus yielded acetyl-D-glucosamine and D-galactose. 

The IL-2 portion of the fusion protein facilitates product interaction with cells displaying cell surface IL-2 receptors, found in high levels on some leukaemia and lymphoma cells, including CTCL cells. Binding appears to trigger internalization of the receptor-fusion protein complex (Figure 9.B1). Sufficient quantities of the latter escape immediate cellular destruction to allow diphtheria toxin-mediated inhibition of cellular protein synthesis. Cell death usually results within hours. 

Table 13.6 Some traditional vaccine preparations that find medical application. In addition to being marketed individually, a number of such products are also marketed as combination vaccines. Examples include diphtheria, tetanus and pertussis vaccines and measles, mumps and rubella vaccines...

Diphtheria and tetanus vaccines are two commonly used toxoid-based vaccine preparations. The initial stages of diphtheria vaccine production entail the growth of Corynebacterium diphtheriae. 

Diphtheria and tetanus vaeeine are two eommonly used toxoid-based vaccine preparations. The initial stages of diphtheria vaccine production entails the growth of Corynebacterium diphtheriae. The toxoid is then prepared by treating the active toxin produced with formaldehyde. The product is normally sold as a sterile aqueous preparation. Tetanus vaccine production follows a similar approach Clostridium tetani is cultured in appropriate media, the toxin is recovered and inactivated by formaldehyde treatment. Again, it is usually marketed as a sterile aqueous-based product. 

The third policy, the Vaccine Injury Compensation Fund, introduced a government-run, no-fault product liability system that reduced the mean and variance of product liability costs associated with four childhood vaccines polio, diphtheria-tetanus, measles-mumps-rubella, and pertussis. 

NORTHRUP, JOHN H. (1891-1987). An American chemist who won a Nobel prize in chemistry in 1946 along with James B. Sumner and Wendell M. Stanley. His work was primarily concerned with isolation and crystallization of enzymes. Many first included the production of the enzyme trypsin in the laboratory and isolation of the first bacterial virus. He was also responsible for producing diphtheria antitoxin in crystalline form. His education was at eastern schools including Harvard. Yale, and Princeton. 

Pyrolysis products were also found to induce prophage X in lysogenic E. ooli K12, strain GY5027 (30), by Inductest III, which was developed by Moreau et al, (31) (Figure 2). The genotoxic effects of pyrolysis products on cultured mammalian cells were also investigated. Trp-P-1, Trp-P-2, IQ and MelQ were found to induce diphtheria toxin-resistant mutants of Chinese hamster lung cells in the presence of S9 mix. The mutation frequencies were 33, 160, 40 and 38 per 106 survivors per Mg of Trp-P-1, Trp-P-2,... 

Ramon G, Descombey P (1925) Sur 1 immunization antitetanique et sur la production de l antitoxine tetanique Compt Rend Soc Biol 93 508-98 Ratts R, Zeng H, Berg EA, Blue C, McComb ME et al. (2003) The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol 160 1139-50... 

This segment includes a detailed example of capture and recovery of extracellular mutant diphtheria toxin from Corymbacterium diphtheria, and some key parameters and conditions for obtaining other products. 

---